For a partial agonist, YK11 only partly activates androgen receptors and will contend instantly with endogenous Testosterone and DHT for receptor activation.YK11 differs from traditional SARMs like LGD-4033 and Ostarine in that it is assessed as both of those a SARM and a steroid because of its chemical structure.PCT is a must – YK-11 may only le